1778 related articles for article (PubMed ID: 33712272)
21. The additive role of angiogenic markers for women with confirmed preeclampsia.
Suresh S; Patel E; Mueller A; Morgan J; Lewandowski WL; Verlohren S; von Dadelszen P; Magee LA; Rana S
Am J Obstet Gynecol; 2023 May; 228(5):573.e1-573.e11. PubMed ID: 36356699
[TBL] [Abstract][Full Text] [Related]
22. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.
Rana S; Burke SD; Karumanchi SA
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1019-S1034. PubMed ID: 33096092
[TBL] [Abstract][Full Text] [Related]
23. Prediction of imminent preeclampsia at 35-37 weeks gestation.
Ciobanu A; Wright A; Panaitescu A; Syngelaki A; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
[TBL] [Abstract][Full Text] [Related]
24. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
[TBL] [Abstract][Full Text] [Related]
25. Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction.
Fosheim IK; Jacobsen DP; Sugulle M; Alnaes-Katjavivi P; Fjeldstad HES; Ueland T; Lekva T; Staff AC
Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100794. PubMed ID: 36334725
[TBL] [Abstract][Full Text] [Related]
26. Human Placenta and Evolving Insights into Pathological Changes of Preeclampsia: A Comprehensive Review of the Last Decade.
Chiorean DM; Cobankent Aytekin E; Mitranovici MI; Turdean SG; Moharer MS; Cotoi OS; Toru HS
Fetal Pediatr Pathol; 2024; 43(1):33-46. PubMed ID: 37906285
[TBL] [Abstract][Full Text] [Related]
27. Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia.
Caniggia I; Winter J; Lye SJ; Post M
Placenta; 2000; 21 Suppl A():S25-30. PubMed ID: 10831118
[TBL] [Abstract][Full Text] [Related]
28. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
[TBL] [Abstract][Full Text] [Related]
29. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
[TBL] [Abstract][Full Text] [Related]
30. Pathophysiology of placental-derived fetal growth restriction.
Burton GJ; Jauniaux E
Am J Obstet Gynecol; 2018 Feb; 218(2S):S745-S761. PubMed ID: 29422210
[TBL] [Abstract][Full Text] [Related]
31. Emerging role for dysregulated decidualization in the genesis of preeclampsia.
Conrad KP; Rabaglino MB; Post Uiterweer ED
Placenta; 2017 Dec; 60():119-129. PubMed ID: 28693893
[TBL] [Abstract][Full Text] [Related]
32. Pathologic maternal and neonatal outcomes associated with programmed embryo transfer: potential etiologies and strategies for prevention.
Conrad KP; von Versen-Höynck F; Baker VL
J Assist Reprod Genet; 2024 Apr; 41(4):843-859. PubMed ID: 38536596
[TBL] [Abstract][Full Text] [Related]
33. Uterine and fetal placental Doppler indices are associated with maternal cardiovascular function.
Tay J; Masini G; McEniery CM; Giussani DA; Shaw CJ; Wilkinson IB; Bennett PR; Lees CC
Am J Obstet Gynecol; 2019 Jan; 220(1):96.e1-96.e8. PubMed ID: 30243605
[TBL] [Abstract][Full Text] [Related]
34. Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms.
Tan L; Chen Z; Sun F; Zhou Z; Zhang B; Wang B; Chen J; Li M; Xiao T; Neuman RI; Niu J; Verdonk K; Lu X; Zhang JV; Danser AHJ; Yang Q; Fan X
Clin Sci (Lond); 2022 Feb; 136(4):257-272. PubMed ID: 35103285
[TBL] [Abstract][Full Text] [Related]
35. Decreased uterine vascularization and uterine arterial expansive remodeling with reduced matrix metalloproteinase-2 and -9 in hypertensive pregnancy.
Lin C; He H; Cui N; Ren Z; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Jan; 318(1):H165-H180. PubMed ID: 31834839
[TBL] [Abstract][Full Text] [Related]
36. Chronic hypertension and superimposed preeclampsia: screening and diagnosis.
Kametas NA; Nzelu D; Nicolaides KH
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1182-S1195. PubMed ID: 35177217
[TBL] [Abstract][Full Text] [Related]
37. Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.
Chen J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():87-165. PubMed ID: 28662830
[TBL] [Abstract][Full Text] [Related]
38. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia.
Qu H; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H661-H681. PubMed ID: 32762557
[TBL] [Abstract][Full Text] [Related]
39. Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?
Mecacci F; Avagliano L; Lisi F; Clemenza S; Serena C; Vannuccini S; Rambaldi MP; Simeone S; Ottanelli S; Petraglia F
Reprod Sci; 2021 Sep; 28(9):2422-2435. PubMed ID: 33211274
[TBL] [Abstract][Full Text] [Related]
40. Decidual and placental NOD1 is associated with inflammation in normal and preeclamptic pregnancies.
Rakner JJ; Silva GB; Mundal SB; Thaning AJ; Elschot M; Ostrop J; Thomsen LCV; Bjørge L; Gierman LM; Iversen AC
Placenta; 2021 Feb; 105():23-31. PubMed ID: 33529885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
